Evidenced-based pharmacotherapy for rate control in atrial fibrillation
Related Experiment Video
Updated: May 13, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
1Point Loma Nazarene University, San Diego, California 92040, USA. hbivens@pointloma.edu
Abstract:
Atrial fibrillation is the most common arrhythmia found in older adults that places them at a high risk for stroke. The presence of AF in an individual, especially older than 60 years, increases the risk of mortality, affects quality of life, and increases prevalence of heart failure. The goal of AF treatment is to maintain heart rate or rhythm control and stroke prevention through anticoagulation. With appropriate management of AF an improvement of symptoms and a reduced morbidity from stroke or heart failure can be achieved. The best treatment for AF is prevention and early diagnosis.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

